Compound shougong powder inhibits the malignant phenotype of hepatocellular carcinoma cells by targeting the DNA damage repair pathway

Author:

Zhu Yong-fu1,Xu Jing2,Wu Jian1,Ma Jia2,Zhang Dong-wei1,Xia Li-ming1,Wang Tian-ming3,Huo Xing-xing1,Song Hang3

Affiliation:

1. The First Affiliated Hospital of Anhui University of Chinese Medicine , Hefei , China

2. Graduate School of Anhui University of Chinese Medicine , Hefei , China

3. School of Integrated Chinese and Western Medicine, Anhui University of Chinese Medicine , Hefei , China

Abstract

AbstractObjectivesCompound Shougong Powder (SGS), a traditional Chinese medicine formulation, has been used to treat cancer for many years with remarkable efficacy. However, the mechanisms underlying the therapeutic effect of SGS in Hepatocellular carcinoma (HCC) are not completely clear.MethodsThe survival and metastasis of HCC cells were examined by CCK-8 assay, EdU assay, Wound-healing and Transwell assay. The anti-tumour effect of SGS was studied using hoechst 33258 staining and flow cytometry. RNA sequencing was applied to detect the underlying mechanism. Comet DNA, qRT-PCR and WB experiments were performed for validation. In addition, HCC nude mouse model was constructed to detect SGS effect in vivo.Key findingsSGS inhibited the proliferation, migration and invasion of HCC cells and induced apoptosis in vitro. In addition, SGS also suppressed tumour growth in a nude mouse model of HCC in a dose-dependent manner. RNA sequencing of the suitably treated HCC cells revealed significant changes in the expression levels of genes involved in the DNA damage repair pathway. The sequencing results were verified by Comet DNA, qRT-PCR, WB assays and molecular docking.ConclusionsTaken together, SGS inhibits the malignant phenotype of HCC cells by down-regulating DNA repair genes and consequently inducing DNA damage.

Funder

Project of High-Level Talents in AHUTCM

Key Project of Anhui Provincial Department of Education

School Level Project of AHUTCM

Publisher

Oxford University Press (OUP)

Subject

Pharmaceutical Science,Pharmacology

Reference27 articles.

1. Cancer statistics, 2022;Siegel;CA Cancer J Clin,2022

2. Llovet JM, Kelley RK, Villanueva A et al. Hepatocellular carcinoma;Nat Rev Dis Primers,2021

3. Mortality analysis of primary liver cancer in the mainland of China from 2004 to 2018;Zhao;Shanghai J. Prev. Med,2021

4. Challenges in liver cancer and possible treatment approaches;Anwanwan;Biochim Biophys Acta Rev Cancer,2020

5. ZHONG LIU FANG JI DA CI DIAN;Zhao

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3